Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8651–8700 of 18433
On August 23, 2023, the Board appointed Rakesh Sehgal to succeed Mr. Graham as the Company’s Executive Vice President and Chief Financial Officer, effective September 15, 2023.
appointed Marietta Edmunds Zakas, the Company’s then-current Executive Vice President and Chief Financial Officer, to serve as President and Chief Executive Officer (“CEO”) and as a director, effective as of August 21, 2023
Steven S. Heinrichs, the Company’s then-current Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary, was appointed to serve as Chief Financial Officer and Chief Legal and Compliance Officer
J. Scott Hall, who stepped down from all of his positions at the Company effective as of the Transition Date.
On August 24, 2023, Milestone Scientific Inc. (the “Company”) announced that Peter J. Milligan, the Company’s part-time Chief Financial Officer, resigned effective September 1, 2023.
terminated without cause the employment of Dominic C. Canuso as the Company’s Executive Vice President, Chief Financial Officer and Corporate Secretary.
Effective August 18, 2023, Arthur J. Bacci, age 64, the Company’s current Executive Vice President and Chief Wealth Officer, will also serve as the Interim Chief Financial Officer of the Company.
Yancey Spruill will continue to serve as the Company’s Chief Executive Officer and a member of the board of directors of the Company (the “Board”) until a successor has been appointed, or upon such other date determined by the Board or an earlier resignation by Mr. Spruill upon thirty days’ notice after the four-month anniversary of date of the Separation Agreement (as defined below).
On August 18, 2023, Mandesh Dosanjh notified the Company that he was stepping down from his position as President and Chief Executive Officer of Pure Sunfarms, Inc.
appointed Shane M. O’Kelly, 54, to the position of President, Chief Executive Officer and as a director of the Company, commencing September 11, 2023.
John C. Stern also was appointed Senior Executive Vice President and Chief Financial Officer of the Company, reporting to Mr. Dolan.
Upon the effectiveness of her appointment, L. Heath Sampson will cease serving as the Company’s interim Chief Financial Officer; he will continue in his current role as the Company’s President and Chief Executive Officer.
the board of directors (the “Board”) of the Company appointed Barbara Gutierrez to be its next Chief Financial Officer with an expected start date of September 18, 2023.
Mr. Reid was then appointed as the Company's President and Chief Executive Officer and appointed as the Company's Secretary, Treasurer and Chief Financial Officer.
(v) Surendra Ajjarapu and Howard Doss were appointed as the Company’s Chief Executive Officer and Chief Financial Officer, respectively (each, a “New Officer”).
(v) Surendra Ajjarapu and Howard Doss were appointed as the Company’s Chief Executive Officer and Chief Financial Officer, respectively (each, a “New Officer”).
On August 17, 2023, Laurie Stelzer notified Mirati Therapeutics, Inc. (the “Company”) of her intention to resign from her position as the Company’s Chief Financial Officer and principal financial and accounting officer, effective as of September 8, 2023
On August 21, 2023, the Board of Directors of the Company (the “Board”) appointed Aaron Ondrey, the Company’s Senior Vice President, Financial Planning and Analysis, as the Company’s Interim Chief Financial Officer and principal financial officer, effective as of the Separation Date.
and Jiyoung Hwang as the Chief Financial Officer and Secretary of the Company.
In connection with his resignation from the Board, Mr. Kim also resigned as the Chief Executive Officer, Chief Financial Officer, President and Secretary of the Company.
On August 21, 2023, in connection with Mr. Kim’s resignation, the Board appointed Paul Kang as the Chief Executive Officer and President of the Company
The Board of Directors of 3M Company (the Company) has appointed Monish Patolawala as 3M President and Chief Financial Officer of the Company, effective September 1, 2023.
On August 18, 2023, S&W Seed Company (“S&W”) entered into a separation agreement with Mark W. Wong in connection with his previously-announced retirement as President and Chief Executive Officer of S&W.
On August 17, 2023, Bryan C. Hanson notified the Company that he planned to step down as Chairman of the Board, President and Chief Executive Officer of the Company and as a member of the Company’s Board, all effective as of August 22, 2023.
Effective August 22, 2023, the Board appointed Ivan Tornos the Company’s President and Chief Executive Officer, and elected Mr. Tornos a member of the Board of Directors to fill the vacancy resulting from Mr. Hanson’s departure from the Board.
Additionally, effective August 22, 2023, Suketu Upadhyay has been appointed to the newly-created position of Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain.
Effective as of August 21, 2023, the Board of Directors of Fidelity National Information Services, Inc. (the “Company”) appointed James Kehoe as the Chief Financial Officer of the Company.
On August 21, 2023, the Company entered into an employment agreement with Arik Maimon pursuant to which Mr. Maimon agreed to serve as Executive Chairman and Chief Executive Officer of the Company
Joseph Hernandez resigned as Chairman, Chief Executive Officer, and a member of the Board of Directors (the “Board”) of Blue Water Biotech, Inc. (the “Company”).
Effective August 16, 2023, Board has appointed Jon Garfield, the Company’s Chief Financial Officer, to serve as the Company’s interim principal executive officer during the pendency of Mr. Sapirstein’s appointment.
announced the appointment of Ms. Cynthia Anderson, C.P.A., as the Company’s Chief Financial Officer
Ms. Anderson replaces Mr. Jerrold Dotson upon his retirement, effective August 21, 2023
appointed Scott Coiante to serve as the Company’s Senior Vice President, Chief Financial Officer and Treasurer, effective August 16, 2023
Effective January 1, 2024, the Company’s Board of Directors (the “Board”) has appointed Mr. Griffiths as President and Chief Executive Officer and as a member of the Board.
On August 21, 2023, the Company also announced that, as part of this leadership transition, Mr. Dufour will depart from his position as President and Chief Executive Officer and as a member of the Board and Bank Board, effective December 31, 2023 (the “Transition Date”).
A. William Higgins, its President and Chief Executive Officer, will retire as an officer of the Company on September 1, 2023.
The Board has appointed Gunnar Kleveland to succeed Mr. Higgins as President and Chief Executive Officer of the Company effective September 1, 2023, and elected Mr. Kleveland to serve as a member of the Board effective that same date.
Mr. Yishai Zohar, age 60, the Company’ President and Chief Executive Officer and as a member of the board of directors, was appointed by the Company’ board of directors on August 16, 2023 to succeed Mr. Maltz as the Company’ Chief Compliance Officer, Corporate Secretary, Treasurer, Interim Principal Financial Officer and Principal Accounting Officer, effective as of August 15, 2023.
Mr. Elliot Maltz resigned as the Chief Financial Officer, Treasurer, Chief Compliance Officer and Corporate Secretary (and principal financial and accounting officer) of the Company, effective August 15, 2023
appointed Simon Harford as the Chief Financial Officer (principal financial officer) of the Company, effective as of August 21, 2023.
the Board appointed Mark Kent, currently serving as the Company’s Interim Chief Executive Officer, as its permanent Chief Executive Officer, thereby removing the interim designation.
On August 15, 2023, Mr. Dianjiang Wang resigned as the chief financial officer of Singularity Future Technology Ltd. (the “Company”).
On August 21, 2023, the Company entered into an employment agreement with Mr. Ying Cao to serve as the chief financial officer of the Company, effective immediately,
On August 20, 2023, J. Scott Hall, President and Chief Executive Officer and a director of Mueller Water Products, Inc. (the “Company”), stepped down from all his positions at the Company effective as of August 21, 2023
Steven S. Heinrichs, the current Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary, was appointed to serve as Chief Financial Officer and Chief Legal and Compliance Officer, effective as of the Transition Date.
On August 15, 2023, the board of directors (the “Board”) of the Company appointed Markita L. Russell as the Chief Financial Officer of the Company.
Douglas McKinnon resigned from his position as the CFO of the Company.
On August 14, 2023, the board of directors of BranchOut Food Inc. (the “Company”) appointed Christopher Coulter as the Company’s Chief Financial Officer effective August 14, 2023
On August 14, 2023, the Company terminated Douglas Durst, the prior Chief Financial Officer of the Company.
The Board of Directors has accepted the Notice as a notice of voluntary resignation by Mrs. Fernandez-McGovern, and not of termination for Good Reason.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.